China Traditional Chinese Medicine Holdings Co. Limited provided unaudited consolidated earnings guidance for the year ended December 31, 2016. For the year, the group expects to record an increase of no less than 50% in consolidated net profit attributable to the shareholders for the year ended December 31, 2016 as compared with the audited consolidated net profit from continuing operations attributable to the shareholders for the year ended December 31, 2015 of approximately RMB 627.5 million. The improvement in the group's results was mainly attributable to the full year profit contribution of the concentrated TCM granules segment from Jiangyin Tianjiang Pharmaceutical Co. Ltd. and its subsidiaries, which were acquired by the group in October 2015.